Reports for HIKMA CANADA LIMITED
Company Name
HIKMA CANADA LIMITED
Totals |
||
Shortage reports |
82 |
|
Actual shortage: | 12 (15%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 1 (1%) | |
Resolved: | 69 (84%) | |
Discontinuation Reports |
4 |
|
To be discontinued: | 3 (75%) | |
Discontinued: | 1 (25%) | |
Reversed: | 0 (0%) | |
Late reports |
16 (19%) |
|
Overdue reports |
10 (67%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
CYANOCOBALAMIN INJECTION USP | 1000MCG | LIQUID | Resolved | 2019-10-03 | 2020-02-04 | 95366 |
PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 2G 0.25G | POWDER FOR SOLUTION | Resolved | 2018-08-10 | 2019-02-20 | 57888 |
PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.25G 2G | POWDER FOR SOLUTION | Resolved | 2022-01-28 | 2022-07-22 | 153835 |
PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 3G 0.375G | POWDER FOR SOLUTION | Resolved | 2018-05-02 | 2018-05-16 | 48144 |
PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 3G 0.375G | POWDER FOR SOLUTION | Resolved | 2022-01-28 | 2022-07-22 | 153839 |
PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 4G 0.5G | POWDER FOR SOLUTION | Resolved | 2018-03-08 | 2018-06-13 | 42266 |
PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Resolved | 2022-01-28 | 2022-07-22 | 153842 |
CEFUROXIME FOR INJECTION, USP | 750MG | POWDER FOR SOLUTION | Actual shortage | 2020-08-13 | 2020-10-31 | 122228 |
CEFUROXIME FOR INJECTION, USP | 1.5G | POWDER FOR SOLUTION | Actual shortage | 2020-08-13 | 2020-08-13 | 122222 |
CEFUROXIME FOR INJECTION, USP | 7.5G | POWDER FOR SOLUTION | Actual shortage | 2020-08-13 | 2020-08-13 | 122225 |
CEFAZOLIN FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2017-09-11 | 2017-11-17 | 21860 |
CEFAZOLIN FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2018-01-08 | 2018-08-08 | 35122 |
CEFAZOLIN FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2018-09-28 | 2018-10-20 | 62580 |
CEFAZOLIN FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2019-07-05 | 2019-12-19 | 88563 |
CEFAZOLIN FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2023-02-02 | 2023-05-08 | 183209 |
CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Resolved | 2017-05-03 | 2017-06-07 | 8815 |
CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Resolved | 2017-09-11 | 2017-11-09 | 21857 |
CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Resolved | 2017-12-18 | 2018-06-05 | 33371 |
CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Resolved | 2019-07-05 | 2021-08-12 | 88566 |
CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Resolved | 2023-01-27 | 2023-07-06 | 182608 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 2G 0.25G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165188 |
PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165193 |
PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165196 |
LIDOCAINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Discontinued | 2024-04-19 | 2024-04-22 | 225805 |
Showing 1 to 4 of 4